Home
Conditions
Graft vs Host Disease

Clinical trial condition

Graft vs Host Disease

Explore clinical trials studying Graft vs Host Disease. Study availability and eligibility vary by location and protocol.

125 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Graft vs Host Disease trial results

Completed

Development and Validation of a Symptom Scale for Children With Chronic Graft-versus-Host Disease

NCT00632658

Conditions: Graft vs Host Disease, Immune System Diseases
Locations: Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Topical Vitamin D in Acute Graft Versus Host Disease of the Skin

NCT03093805

Conditions: Graft vs Host Disease, Immune System Diseases
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Completed

CEC Count Changes to Support GvHD Diagnosis.

NCT02064972

Conditions: Complications of Organ Transplant Stem Cells, Endothelial Dysfunction, Graft vs Host Disease, +1 more
Locations: A.O. Spedali Civili of Brecia Brescia, Italy

View Trial Details

Completed

Ruxolitinib for Steroid-refractory GVHD

NCT02997280

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +8 more
Locations: First Pavlov State Medical University of St. Petersburg Saint Petersburg, Russia

View Trial Details

Completed

Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT

NCT02398708

Conditions: Graft Versus Host Disease, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, +2 more
Locations: UF Health Cancer Hospital Gainesville, Florida, United States

View Trial Details

Completed

A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host Disease

NCT01700036

Conditions: Graft vs Host Disease, Immune System Diseases
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

University of Michigan Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Completed

Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCT

NCT03575767

Conditions: Disease Attributes, Graft vs Host Disease, Hematologic Diseases, +9 more
Locations: Affiliated Hospital to Academy of Military Medical Sciences Beijing, Beijing Municipality, China

View Trial Details

Completed

The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers

NCT00001873

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +36 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation

NCT00670423

Conditions: Graft vs Host Disease, Immune System Diseases, Peripheral Blood Stem Cell Transplantation, +1 more
Locations: Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell Transplant

NCT01790568

Conditions: Graft vs Host Disease, Hematologic Diseases, Hematologic Neoplasms, +5 more
Locations: University of Michigan Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Graft vs Host Disease

Graft vs Host Disease trial results

Related conditions